Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Litong Qi"'
Association between basal septal hypertrophy and left ventricular geometry in a community population
Autor:
Lan Gao, Wei Ma, Min Li, Ying Yang, Litong Qi, Baowei Zhang, Chonghui Wang, Yan Zhang, Yong Huo
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Left ventricular (LV) geometry is closely associated with cardiovascular disease; however, few studies have evaluated the relationship between basal septal hypertrophy (BSH) and LV geometry. In this study, we examined the relation
Externí odkaz:
https://doaj.org/article/74e6e710ca1643dcbc90e39189fc44be
Publikováno v:
Cardiovascular Ultrasound, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background The left atrium (LA) is closely related to left ventricular diastolic function. Two-dimensional speckle tracking strain and strain rate (SR) imaging has been applied in the study of LA function. We intended to explore the relation
Externí odkaz:
https://doaj.org/article/889369cc6fea4c959a9b14676a599bbd
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Left atrial (LA) size is often used as a surrogate marker of LA function in clinical practice, with larger atrial thought to represent a “dysfunctioning” atrium, since there is no accepted ‘gold’ standard to evaluate LA fu
Externí odkaz:
https://doaj.org/article/9eb92040b7094bbe82cd8d6577ff6f29
Autor:
Litong Qi, Jiyan Chen, Xiaodong Li, Xiaoyong Qi, Chunhua Ding, Xiaoping Chen, Xiang Gu, Wenliang Xiao, Shuiping Zhao, Yugang Dong, Mingqi Zheng, Kai Huang, Liangqiu Tang, Xiaomei Guo, Fang Wang, Guosheng Fu, Junxia Li, Yong Huo
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundTo evaluate the safety and efficacy of hybutimibe plus atorvastatin for lipid control in hypercholesterolemia patients with atherosclerotic cardiovascular disease risk equivalent.MethodsIn this double-blind phase III study, we 1:1 randomly
Externí odkaz:
https://doaj.org/article/b96ba4db993946558feb843b4bb828fb
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background We examined the relationship between epicardial fat thickness (EFT) measured by echocardiography and left ventricular diastolic function parameters in a Beijing community population. Methods We included 1004 participants in this s
Externí odkaz:
https://doaj.org/article/87c0b545c1724ee2b2f27cc23a4e88a1
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Hypertension and arterial vasculopathy may be mutual causes and effects. It is unknown whether carotid intima-media thickness (cIMT) is reliably predictive of the presence of newly developed hypertension in the Chinese population.
Externí odkaz:
https://doaj.org/article/54bbda9e9bd045e392335249ff1e4900
Publikováno v:
International Journal of Hypertension, Vol 2021 (2021)
Blood pressure variability (BPV) has been identified as an important risk factor for cardiovascular events. The white coat effect (WCE), which is measured as the first systolic blood pressure (SBP) measurement minus the mean of the second and third m
Externí odkaz:
https://doaj.org/article/3797216654fd4a618ebefdccb5bf4665
Autor:
Mohetaboer Momin, Fangfang Fan, Jianping Li, Xianhui Qin, Jia Jia, Litong Qi, Yan Zhang, Yong Huo
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Previous studies indicated that homocysteine (Hcy) is associated with higher peripheral systolic blood pressure (pSBP). There have been few data on the relationship between Hcy and central SBP (cSBP). A total of 4,364 Chinese subjects from t
Externí odkaz:
https://doaj.org/article/c0e2e3eb9e9b45acaeae09645a868ba5
Autor:
Litong Qi, Shuiping Zhao, Jiyan Chen, Mei Zhang, Xiaodong Li, Yugang Dong, Xiaomei Guo, Kai Huang, Fang Wang, Yong Huo, Junbo Ge
Publikováno v:
Cardiology Plus. 7:77-84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de3b0ed75820f1d5b6ad3c2c1ac3a4c8
https://doi.org/10.1097/cp9.0000000000000012
https://doi.org/10.1097/cp9.0000000000000012
Autor:
Xin Li, Yong Huo, Lei Qian, Zhijun Huang, Yimin Cui, Haoyu Li, Xia Zhao, Litong Qi, Huan Deng, Guoping Yang
Publikováno v:
JACC: Asia. 1:411-415
The aim of the studies was to evaluate the safety, tolerability, and efficacy of tafolecimab, a novel proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody, in Chinese healthy volunteers and patients with hypercholesterolemia. Fif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be7a23b8a8a66ca5b6ae3fa49fec0ef0
https://doi.org/10.1016/j.jacasi.2021.09.002
https://doi.org/10.1016/j.jacasi.2021.09.002